Latest Articles
8 startups funded by PXN’s PraeSeed programme - businesscloud.co.uk
8 startups funded by PXN’s PraeSeed programme businesscloud.co.uk
Published: Dec. 3, 2025, 7:23 a.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - sharewise.com
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia sharewise.com
Published: Dec. 3, 2025, 5:04 a.m.
Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything - Times of India
Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything Times of India
Published: Dec. 3, 2025, 12:36 a.m.
Best Walmart Cyber Monday 2025 deals: Legos, Dyson vacuums, AirPods discounts - Mashable
Best Walmart Cyber Monday 2025 deals: Legos, Dyson vacuums, AirPods discounts Mashable
Published: Dec. 2, 2025, 9:20 p.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - Business Wire
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia Business Wire
Published: Dec. 2, 2025, 1:05 p.m.
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia - Stock Titan
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia Stock Titan
Published: Dec. 2, 2025, 1:05 p.m.
Singapore start-up raises US$1.5m to redefine menstrual health - FemTech World
Singapore start-up raises US$1.5m to redefine menstrual health FemTech World
Published: Dec. 2, 2025, 12:49 p.m.
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia - MarketScreener
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia MarketScreener
Published: Dec. 2, 2025, 7:36 a.m.
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia - MarketScreener
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia MarketScreener
Published: Dec. 2, 2025, 7:36 a.m.
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia - Bayer
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia Bayer
Published: Dec. 2, 2025, 7:30 a.m.
Link copied to clipboard!